CELLULAR TRANSFORMATION BY HUMAN T-CELL LEUKEMIA VIRUS: POSSIBLE ROLE OF T-CELL GROWTH FACTOR AND PLATELET-DERIVED GROWTH FACTOR NLM AIDSLINE Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


CELLULAR TRANSFORMATION BY HUMAN T-CELL LEUKEMIA VIRUS: POSSIBLE ROLE OF T-CELL GROWTH FACTOR AND PLATELET-DERIVED GROWTH FACTOR

UCLA Symp Mol Cell Biol; New Ser 23:357-67 1985. Unique Identifier : AIDSLINE ICDB/87628848
Ratner L; Arya SK; Gallo RC; Wong-Staal F; Lab. of Tumor Cell Biology, Developmental Therapeutics Program,; NCI, Bethesda, MD 20205


Abstract: Efforts to establish T lymphocytes in culture led to the discovery of T-cell growth factor (TCGF), its purification and characterization, and studies on the structure and function of its genetic locus. Application of this culture system to malignant T cells led to the identification of an exogenous retrovirus, human T-cell leukemia virus (HTLV), associated with a distinct form of clinical disease. TCGF receptors are universally present on HTLV-transformed cell lines despite the fact that many of these cell lines neither require nor produce TCGF. Characterization of TCGF and regulation of TCGF production are described. Soon after its discovery, TCGF was utilized for the growth of malignant T cells as well. This allowed the establishment of several cell lines from patients with cutaneous T-cell lymphomas. These cell lines recapitulated the morphology, cytochemical staining, and monoclonal antibody surface reactivity of the fresh tumor tissue. It was from one of these cell lines that a retrovirus was detected by the presence of particle-associated transverse transcriptase activity in the medium and the presence of c-type particles by electron microscopy. This virus has been called HTLV and has been extensively characterized. The presence of TCGF receptors on all HTLV-transformed cell lines, the existence of cell lines growing in the absence of added TCGF, and the finding of constitutive production of TCGF by some of the cell lines suggested that these malignant T cells may be producing and responding to their own TCGF, and driving their own proliferation. The failure to detect TCGF in the medium of all cell lines growing independently of exogenous TCGF did not exclude the possible involvement of low levels of extracellular TCGF or the presence of intracellular TCGF. However, the TCGF mRNA could not be detected in many of these TCGF-independent cell lines. Studies of oncogene expression in attempting to elucidate further the mechanism of cellular transformation have demonstrated the presence of c-sis transcripts in many HTLV-transformed cell lines, but no other hematopoietic cells examined. Characterization of the expressed c-sis sequences revealed that (1) they are capable of transforming 3T3 cells and (2) the sequence of the v-sis homologous region is identical to that of the normal gene. However, complete understanding of the role of sis expression in HTLV-induced transformation of T lymphocytes requires further investigation. (99 Refs)
Keywords: *Cell Transformation, Neoplastic *Cell Transformation, Viral Human HTLV-BLV Viruses Interleukin-2/GENETICS/*PHYSIOLOGY Oncogenes Platelet-Derived Growth Factor/*PHYSIOLOGY Proto-Oncogenes MEETING PAPER

KWDcelltransformation,neoplasticKWDcelltransformation,viralhumanhtlv-blvvirusesinterleukin-2/genetics/KWDphysiologyoncogenesplatelet-derivedgrowthfactor/KWDphysiologyproto-oncogenesmeetingpaper
870330
M8730285


Copyright © 1987 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .